Acute kidney injury in hematological patients treated with CAR-T cells: risk factors, clinical presentation and impact on outcomes

Abstract Chimeric antigen receptor T-cell (CAR-T) therapy has revolutionized the treatment of hematologic malignancies, yet it carries significant risks, including acute kidney injury (AKI). In this study, we investigated the risk factors and clinical impact of AKI in patients undergoing CAR-T cell...

Whakaahuatanga katoa

Ngā taipitopito rārangi puna kōrero

Ngā kaituhi matua:	Elisa Russo, Massimiliano Gambella, Anna Maria Raiola, Elena Beltrametti, Valentina Zanetti, Giuseppe Chirco, Francesca Viazzi, Emanuele Angelucci, Pasquale Esposito
Hōputu:	Artigo
Reo:	Inglês
I whakaputaina:	Nature Portfolio 2024-11-01
Rangatū:	Scientific Reports
Ngā marau:	Acute kidney injury Performance status CAR-T cell therapy Cytokine release syndrome Disease-free survival Mortality
Urunga tuihono:	https://doi.org/10.1038/s41598-024-77720-z
Ngā Tūtohu:	Tāpirihia he Tūtohu Kāore He Tūtohu, Me noho koe te mea tuatahi ki te tūtohu i tēnei pūkete!